These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6145748)

  • 1. [Cyclic GMP: its biosynthesis and physiological role].
    Deguchi T
    Seikagaku; 1984 Jan; 56(1):19-38. PubMed ID: 6145748
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of cyclic GMP formation by soluble guanylate cyclase: stimulation by NO-containing compounds.
    Böhme E; Grossmann G; Herz J; Mülsch A; Spies C; Schultz G
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():259-66. PubMed ID: 6145322
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclic-GMP-regulated enzymes and their possible physiological functions.
    Walter U
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():249-58. PubMed ID: 6145321
    [No Abstract]   [Full Text] [Related]  

  • 4. EDRF is an intracellular second messenger and autacoid to regulate cyclic GMP synthesis in many cells.
    Murad F; Ishii K; Förstermann U; Gorsky L; Kerwin JF; Pollock J; Heller M
    Adv Second Messenger Phosphoprotein Res; 1990; 24():441-8. PubMed ID: 1976334
    [No Abstract]   [Full Text] [Related]  

  • 5. Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP.
    Rapoport RM; Murad F
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):281-96. PubMed ID: 6147363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of unsaturated fatty acids in the modulation of the guanylate cyclase-guanosine 3',5' monophosphate system of colonic mucosa.
    Craven PA; DeRubertis FR
    J Lab Clin Med; 1980 Nov; 96(5):879-92. PubMed ID: 6106658
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
    Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular mechanism involved in the synthesis of cyclic GMP in nervous tissues.
    Deguchi T; Ohsako S; Nakane M; Ichikawa M; Yoshioka M
    J Neural Transm Suppl; 1983; 18():369-78. PubMed ID: 6135749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanylate cyclase: inhibition by light in retinal photoreceptors.
    Bensinger RE; Fletcher RT; Chader GJ
    Science; 1974 Jan; 183(4120):86-7. PubMed ID: 4148703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of cyclic GMP in visnal process-activation of cyclic GMP phosphodiesterase by light and ATP (author's transl)].
    Miki N
    Tanpakushitsu Kakusan Koso; 1976 Aug; 21(8):605-11. PubMed ID: 9667
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.
    Sadoff JD; Scholz PM; Tse J; Weiss HR
    J Clin Invest; 1996 Aug; 98(3):838-45. PubMed ID: 8698876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium-dependent vasodilator-and nitrovasodilator-induced relaxation may be mediated through cyclic GMP formation and cyclic GMP-dependent protein phosphorylation.
    Rapoport RM; Draznin MB; Murad F
    Trans Assoc Am Physicians; 1983; 96():19-30. PubMed ID: 6149646
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [cGMP and neuronal function].
    Nakane M
    Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1019-25. PubMed ID: 1972582
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.
    Brunner F; Schmidt K; Nielsen EB; Mayer B
    J Pharmacol Exp Ther; 1996 Apr; 277(1):48-53. PubMed ID: 8613957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible association of decrease of ATP-induced vascular relaxation with reduction of cyclic GMP during aging.
    Ueda H; Moritoki H
    Arch Int Pharmacodyn Ther; 1991; 310():35-45. PubMed ID: 1663332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
    Murad F; Waldman S; Molina C; Bennett B; Leitman D
    Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guanylate cyclase and cyclic GMP-dependent protein kinase in the brain (author's transl)].
    Nakazawa K
    Tanpakushitsu Kakusan Koso; 1977; 22(6):619-24. PubMed ID: 22100
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cellular mechanism involved in the synthesis of cyclic GMP in nervous tissues].
    Nakane M; Deguchi T
    Tanpakushitsu Kakusan Koso; 1984 Nov; 29(12 Suppl):1267-78. PubMed ID: 6152062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.